Search
Quote for "exact phrases"
       
Sort order:    
Results 1 - 50 of 430

Ketamine Transiently Alters Brain Network Dynamics Linked to Rumination and Somatosensory Processing
This Month in Psychpharmacology added 09/22/2026. CME credit is not available

Sexual Dysfunction
Side Effect Management added 09/18/2026. CME credit is not available

Dry Mouth
Side Effect Management added 09/18/2026. CME credit is not available

Antidepressant-Induced Excessive Sweating (ADIES)
Side Effect Management added 09/18/2026. CME credit is not available

DT120 Lysergide ODT Receives FDA Breakthrough Therapy Designation for Major Depressive Disorder
This Month in Psychpharmacology added 09/15/2026. CME credit is not available

Guess What! A Game Show Look Ahead at Some of the Most Promising Psychiatric Advances on the Horizon
Encore Presentation added 08/31/2026. CME credit is available

40-Year-Old With Residual Symptoms of Major Depressive Disorder
MPP: Drills added 08/18/2026. CME credit is available

Navigating the Storm: Real-World Diagnosis and Management of Bipolar Depression Clouded by Mixed and Anxious Features
Encore Presentation added 07/31/2026. CME credit is available

The Personal Touch: Utilizing Biotypes and Biomarkers in the Diagnosis and Management of Difficult-to-Treat Depression
Encore Presentation added 07/31/2026. CME credit is available

Low-Dose Buprenorphine May Enhance Ketamine's Antisuicidal Effects in Major Depression
This Month in Psychpharmacology added 07/09/2026. CME credit is not available

Fast and Curious: Exciting Advances in the Rapid-Acting and Targeted Treatment of Major Depressive Disorder
Encore Presentation added 07/02/2026. CME credit is available

22-Year-Old With Treatment-Resistant Depression Seeking Gender-Affirming Care
MPP: Drills added 05/12/2026. CME credit is available

Choosing an Adjunctive Antipsychotic for Major Depressive Disorder
This Month in Psychpharmacology added 05/06/2026. CME credit is not available

Goals to Bring Home: Applying What You Have Learned Into Practice
Encore Presentation added 04/29/2026. CME credit is available

Esketamine for Depressed Adolescents at Imminent Suicide Risk
This Month in Psychpharmacology added 04/07/2026. CME credit is not available

Cognition
Screening and Diagnosis added 04/06/2026. CME credit is not available

Functioning and Quality of Life
Screening and Diagnosis added 04/06/2026. CME credit is not available

Suicide Risk
Screening and Diagnosis added 04/06/2026. CME credit is not available

Rethinking Mood Disorder Treatment with Immunometabolic Insights
This Month in Psychpharmacology added 03/19/2026. CME credit is not available

Exercise Demonstrates Moderate Effects for Depression and Anxiety Across the Lifespan
This Month in Psychpharmacology added 03/19/2026. CME credit is not available

Ketogenic Diet Shows Modest Short-Term Benefit in Treatment-Resistant Depression
This Month in Psychpharmacology added 03/05/2026. CME credit is not available

Yes, No, or Maybe So? Antidepressant Use in Pediatric Bipolar Spectrum Disorders
Encore Presentation added 02/24/2026. CME credit is available

Serial Intravenous Ketamine Infusions Not Superior to Usual Inpatient Care for Depression
This Month in Psychpharmacology added 02/10/2026. CME credit is not available

Hope Is The Thing With Feathers: Addressing Anhedonia in Patients With Depression
Encore Presentation added 01/29/2026. CME credit is available

NRX-101 Development Expanded to Include TMS for Depression
This Month in Psychpharmacology added 01/15/2026. CME credit is not available

Advancing the Climb to Overcome Difficult-to-Treat Depression
Encore Presentation added 12/30/2025. CME credit is available

Finding a Pot of Gold Among the Mix: Strategies to Address the Syndrome of Depression Across the Rainbow of Mood Disorders
Encore Presentation added 12/26/2025. CME credit is available

Heart Rate, Cholesterol, and Weight Shifts Vary Widely Across Antidepressant Classes
This Month in Psychpharmacology added 12/12/2025. CME credit is not available

Complex Depression: Treating Beyond the Standard Algorithm
Podcast Activity added 12/03/2025. CME credit is available

FDA Approves Lumateperone as Adjunctive Treatment for Major Depressive Disorder
This Month in Psychpharmacology added 11/06/2025. CME credit is not available

Tardive Dyskinesia
Side Effect Management added 10/30/2025. CME credit is not available

Akathisia
Side Effect Management added 10/30/2025. CME credit is not available

Switching from Oral Medications to Cariprazine
Switching and Deprescribing added 10/30/2025. CME credit is not available

Switching from Oral Medications to Brexpiprazole
Switching and Deprescribing added 10/29/2025. CME credit is not available

Switching from Oral Medications to Risperidone
Switching and Deprescribing added 10/28/2025. CME credit is not available

Switching from Oral Medications to Quetiapine
Switching and Deprescribing added 10/28/2025. CME credit is not available

Switching from Oral Medications to Olanzapine
Switching and Deprescribing added 10/28/2025. CME credit is not available

Switching from Oral Medications to Lurasidone
Switching and Deprescribing added 10/28/2025. CME credit is not available

Switching from Oral Medications to Lumateperone
Switching and Deprescribing added 10/28/2025. CME credit is not available

Switching from Oral Medications to Asenapine
Switching and Deprescribing added 10/28/2025. CME credit is not available

Switching from Oral Medications to Aripiprazole
Switching and Deprescribing added 10/28/2025. CME credit is not available

Medication-Induced Rash
Side Effect Management added 10/25/2025. CME credit is not available

Depression
Screening and Diagnosis added 10/25/2025. CME credit is not available

Switching Between Serotonergic "Antidepressants"
Switching and Deprescribing added 10/25/2025. CME credit is not available

Pediatric Major Depressive Disorder
Treatment Algorithms added 10/24/2025. CME credit is not available

US FDA Approvals for Serotonergic "Antidepressants"
Medication Tips and Pearls added 10/24/2025. CME credit is not available

Binding Profiles of Serotonin-Dopamine Antagonists and Partial Agonists (SDA-PAs)
Medication Tips and Pearls added 10/23/2025. CME credit is not available

Dose Equivalence: D2 Antagonists and SDA-PAs
Medication Tips and Pearls added 10/22/2025. CME credit is not available

Switching Between Serotonin-Dopamine Antagonists and Partial Agonists (SDA-PAs)
Switching and Deprescribing added 10/22/2025. CME credit is not available

Lurasidone Efficacious for Depression Across Psychiatric Diagnoses
This Month in Psychpharmacology added 10/10/2025. CME credit is not available

<< Back   1 2 3 4 5 6 7 8 9   Next >>